Comparative split-face study of 5-aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin

Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) (ALA‐PDT) using intense pulsed light (IPL) as a light source (IPL‐ALA‐PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL‐ALA‐PDT protoc...

Full description

Saved in:
Bibliographic Details
Published inJournal of dermatology Vol. 37; no. 12; pp. 1005 - 1010
Main Authors KOSAKA, Sachiko, YASUMOTO, Minako, AKILOV, Oleg E., HASAN, Tayyaba, KAWANA, Seiji
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.2010
Subjects
Online AccessGet full text
ISSN0385-2407
1346-8138
1346-8138
DOI10.1111/j.1346-8138.2010.00946.x

Cover

Abstract Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) (ALA‐PDT) using intense pulsed light (IPL) as a light source (IPL‐ALA‐PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL‐ALA‐PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0–20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non‐linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose–response curve with R2 = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500–670 and 870–1400 nm, 23–30 J/cm2) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4‐week intervals with follow‐up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL‐ALA‐PDT‐treated side of the face showed greater improvement than the IPL‐treated side. However, all IPL‐ALA‐PDT‐treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL‐ALA‐PDT protocol requires optimization for photorejuvenation in Asians.
AbstractList Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) (ALA-PDT) using intense pulsed light (IPL) as a light source (IPL-ALA-PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL-ALA-PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0-20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non-linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose-response curve with R² = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500-670 and 870-1400 nm, 23-30 J/cm²) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4-week intervals with follow-up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL-ALA-PDT-treated side of the face showed greater improvement than the IPL-treated side. However, all IPL-ALA-PDT-treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL-ALA-PDT protocol requires optimization for photorejuvenation in Asians.
Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) (ALA‐PDT) using intense pulsed light (IPL) as a light source (IPL‐ALA‐PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL‐ALA‐PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0–20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non‐linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose–response curve with R 2  = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500–670 and 870–1400 nm, 23–30 J/cm 2 ) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4‐week intervals with follow‐up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL‐ALA‐PDT‐treated side of the face showed greater improvement than the IPL‐treated side. However, all IPL‐ALA‐PDT‐treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL‐ALA‐PDT protocol requires optimization for photorejuvenation in Asians.
Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) (ALA‐PDT) using intense pulsed light (IPL) as a light source (IPL‐ALA‐PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL‐ALA‐PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0–20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non‐linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose–response curve with R2 = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500–670 and 870–1400 nm, 23–30 J/cm2) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4‐week intervals with follow‐up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL‐ALA‐PDT‐treated side of the face showed greater improvement than the IPL‐treated side. However, all IPL‐ALA‐PDT‐treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL‐ALA‐PDT protocol requires optimization for photorejuvenation in Asians.
Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) (ALA-PDT) using intense pulsed light (IPL) as a light source (IPL-ALA-PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL-ALA-PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0-20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non-linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose-response curve with R² = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500-670 and 870-1400 nm, 23-30 J/cm²) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4-week intervals with follow-up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL-ALA-PDT-treated side of the face showed greater improvement than the IPL-treated side. However, all IPL-ALA-PDT-treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL-ALA-PDT protocol requires optimization for photorejuvenation in Asians.Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) (ALA-PDT) using intense pulsed light (IPL) as a light source (IPL-ALA-PDT) has been used for photorejuvenation, but it is unclear if this protocol can be applied to darker skin types. We performed this study to assess our IPL-ALA-PDT protocol for photorejuvenation in Asian skin. To determine an appropriate dose, ALA ointment (0-20%) was applied to the upper arm of five healthy volunteers and the fluorescence intensity (FI) was measured using a spectrofluorometer. Non-linear regression analysis of FI 2 h after ALA application with global fitting gave a typical sigmoid dose-response curve with R² = 0.9705 and saturation after 5% ALA. The entire faces of 16 Japanese women with photodamage were then treated with IPL (500-670 and 870-1400 nm, 23-30 J/cm²) 2 h after application of 5% ALA to one side of the face. Three treatments were delivered at 4-week intervals with follow-up visits. Comparative analysis of photorejuvenation showed noticeable improvements on both sides of the face, although the reduction in the photoaging score from baseline did not differ significantly between the two sides in all subjects. Despite this finding, 75% of the patients felt that the IPL-ALA-PDT-treated side of the face showed greater improvement than the IPL-treated side. However, all IPL-ALA-PDT-treated sides showed adverse effects such as erythema and pain. Therefore, we conclude that the IPL-ALA-PDT protocol requires optimization for photorejuvenation in Asians.
Author AKILOV, Oleg E.
KOSAKA, Sachiko
HASAN, Tayyaba
YASUMOTO, Minako
KAWANA, Seiji
Author_xml – sequence: 1
  givenname: Sachiko
  surname: KOSAKA
  fullname: KOSAKA, Sachiko
  organization: Department of Dermatology, Nippon Medical School, Tokyo, Japan
– sequence: 2
  givenname: Minako
  surname: YASUMOTO
  fullname: YASUMOTO, Minako
  organization: Department of Dermatology, Nippon Medical School, Tokyo, Japan
– sequence: 3
  givenname: Oleg E.
  surname: AKILOV
  fullname: AKILOV, Oleg E.
  organization: Wellman Center for Photomedicine, Massachusetts General Hospital, Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
– sequence: 4
  givenname: Tayyaba
  surname: HASAN
  fullname: HASAN, Tayyaba
  organization: Wellman Center for Photomedicine, Massachusetts General Hospital, Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
– sequence: 5
  givenname: Seiji
  surname: KAWANA
  fullname: KAWANA, Seiji
  organization: Department of Dermatology, Nippon Medical School, Tokyo, Japan
BackLink https://cir.nii.ac.jp/crid/1573668925623547392$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/21083701$$D View this record in MEDLINE/PubMed
BookMark eNqNkctuEzEUhkeoiKaFV0BeILGa4Mv4JiGkKpRwiQAhEEvLGXuI04k9jD1p8gY8Np5OyYJVvbCPfL7__NL5L4ozH7wtCoDgHOXzajtHpGKlQETMMcy_EMqKzQ-PitmpcVbMIBG0xBXk58VFjFsIsaQIPinOMYKCcIhmxZ9F2HW618ntLYhd61LZ6DqXaTBHEBpAS71zPrR2P7TOuxro2hnQbUIK5uhzrwZpY3vdHcGtSxvgfLI-WtANbbQGtO7XJoEm9JOkt9thb322C36cfhWd9iDeOP-0eNzoLHl2_14WP95df1-8L1dflh8WV6uyrqhgZY0l1hCaSmPKjSSQsspyiUyN1kxTbalsLBfMQsillZyucSW5NLRpjEWmIZfFy2lu14ffg41J7Vysbdtqb8MQlYCiYpDKKpPP78lhvbNGdb3b6f6o_i0vA2IC6j7E2NvmhCCoxpzUVo1xqDEONeak7nJShyx985-0duluK6nXrn3IgNfTgFvX2uODjdXHt9e5yPIXk9w7l63HG1FOGBMSU4YJrTiROGPlhLmY7OHkovsbxTjhVP38vFSrJZXfPi2E-kr-Avkax5M
CitedBy_id crossref_primary_10_1111_jdv_16044
crossref_primary_10_1016_j_pdpdt_2016_02_005
crossref_primary_10_1111_exd_12391
crossref_primary_10_1007_s00403_016_1666_3
crossref_primary_10_1016_j_pdpdt_2014_10_003
crossref_primary_10_1016_j_pdpdt_2019_101606
crossref_primary_10_1080_09546634_2019_1569752
crossref_primary_10_1016_j_pdpdt_2023_103902
crossref_primary_10_1002_lsm_23492
crossref_primary_10_1097_DSS_0000000000000528
crossref_primary_10_1159_000507926
crossref_primary_10_1159_000524408
crossref_primary_10_1016_j_ad_2014_10_004
crossref_primary_10_1111_phpp_12140
crossref_primary_10_1016_j_adengl_2015_04_001
crossref_primary_10_3390_medicina61020207
crossref_primary_10_1080_14764172_2020_1740272
crossref_primary_10_3109_09546634_2014_933163
crossref_primary_10_1002_jbio_201700357
crossref_primary_10_1111_bjd_14970
crossref_primary_10_1111_j_1610_0387_2012_08046_x
crossref_primary_10_1016_j_ymeth_2016_07_008
crossref_primary_10_23736_S0392_0488_18_05982_5
Cites_doi 10.1111/j.1524-4725.2005.31924
10.1111/j.1524-4725.2007.33092.x
10.1080/147641700510037725
10.1001/archderm.141.10.1247
10.1111/j.1524-4725.2006.32163.x
10.1016/j.det.2006.09.013
ContentType Journal Article
Copyright 2010 Japanese Dermatological Association
2010 Japanese Dermatological Association.
Copyright_xml – notice: 2010 Japanese Dermatological Association
– notice: 2010 Japanese Dermatological Association.
DBID BSCLL
RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1346-8138.2010.00946.x
DatabaseName Istex
CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1346-8138
EndPage 1010
ExternalDocumentID 21083701
10_1111_j_1346_8138_2010_00946_x
JDE946
10028275867
ark_67375_WNG_LG59RKC8_P
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29K
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
B.R
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
ROL
RX1
SAMSI
SJN
SUPJJ
SV3
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
RYH
AEUQT
AFPWT
WRC
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4586-c292a00d4a257d930564e791dc1b6a5ae59fe786e0079e975b24979d5ffde1df3
IEDL.DBID DR2
ISSN 0385-2407
1346-8138
IngestDate Thu Sep 04 18:50:19 EDT 2025
Wed Feb 19 01:49:10 EST 2025
Wed Oct 01 04:44:08 EDT 2025
Thu Apr 24 23:05:16 EDT 2025
Wed Jan 22 17:09:36 EST 2025
Thu Jun 26 22:33:15 EDT 2025
Sun Sep 21 06:20:28 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2010 Japanese Dermatological Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4586-c292a00d4a257d930564e791dc1b6a5ae59fe786e0079e975b24979d5ffde1df3
Notes ArticleID:JDE946
ark:/67375/WNG-LG59RKC8-P
istex:222F975D3715468BC591FFA04FC9C403B2D106FB
Present address: Department of Dermatology, University of Pittsburgh, 145 Lothrop Hall, Suite 101, Pittsburgh, PA 15206, USA.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 21083701
PQID 808460594
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_808460594
pubmed_primary_21083701
crossref_primary_10_1111_j_1346_8138_2010_00946_x
crossref_citationtrail_10_1111_j_1346_8138_2010_00946_x
wiley_primary_10_1111_j_1346_8138_2010_00946_x_JDE946
nii_cinii_1573668925623547392
istex_primary_ark_67375_WNG_LG59RKC8_P
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-12
2010-12-01
December 2010
2010-12-00
2010-Dec
20101201
PublicationDateYYYYMMDD 2010-12-01
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle Journal of dermatology
PublicationTitleAlternate J Dermatol
PublicationYear 2010
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split face comparison study. J Drugs Dermatol 2005; 4: 35-38.
Gold MH. Photodynamic therapy in dermatology: the next five years. Dermatol Clin 2007; 25: 119-120.
Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005; 7: 21-24.
Kosaka S, Kawana S. Photodynamic therapy in aesthetic dermatology. Aesthetic Dermatol 2007; 17: 115-121.
Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005; 141: 1247-1252.
Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006; 32: 795-801.
Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33: 449-454.
Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990; 136: 891-897.
Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005; 31: 1179-1187.
2007; 17
2005; 4
2005; 31
2005; 7
2006
1990; 136
2005; 141
2007; 33
2006; 32
2006; 16
2007; 25
e_1_2_5_8_2
e_1_2_5_7_2
e_1_2_5_10_2
Hasan T (e_1_2_5_2_2) 2006
e_1_2_5_5_2
e_1_2_5_12_2
Divaris DXG (e_1_2_5_3_2) 1990; 136
e_1_2_5_11_2
Babilas P (e_1_2_5_4_2) 2006; 16
Alster TS (e_1_2_5_9_2) 2005; 4
Kosaka S (e_1_2_5_6_2) 2007; 17
References_xml – reference: Gold MH. Photodynamic therapy in dermatology: the next five years. Dermatol Clin 2007; 25: 119-120.
– reference: Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split face comparison study. J Drugs Dermatol 2005; 4: 35-38.
– reference: Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990; 136: 891-897.
– reference: Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005; 31: 1179-1187.
– reference: Kosaka S, Kawana S. Photodynamic therapy in aesthetic dermatology. Aesthetic Dermatol 2007; 17: 115-121.
– reference: Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005; 7: 21-24.
– reference: Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33: 449-454.
– reference: Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006; 32: 795-801.
– reference: Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
– reference: Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005; 141: 1247-1252.
– volume: 4
  start-page: 35
  year: 2005
  end-page: 38
  article-title: Photorejuvenation of facial skin with topical 20% 5‐aminolevulinic acid and intense pulsed light treatment: a split face comparison study
  publication-title: J Drugs Dermatol
– volume: 17
  start-page: 115
  year: 2007
  end-page: 121
  article-title: Photodynamic therapy in aesthetic dermatology
  publication-title: Aesthetic Dermatol
– volume: 31
  start-page: 1179
  year: 2005
  end-page: 1187
  article-title: Intense pulsed light as a nonablative approach to photoaging
  publication-title: Dermatol Surg
– volume: 7
  start-page: 21
  year: 2005
  end-page: 24
  article-title: Ultrastructural changes seen after ALA‐IPL photorejuvenation: a pilot study
  publication-title: J Cosmet Laser Ther
– volume: 25
  start-page: 119
  year: 2007
  end-page: 120
  article-title: Photodynamic therapy in dermatology: the next five years
  publication-title: Dermatol Clin
– start-page: 537
  year: 2006
  end-page: 548
– volume: 32
  start-page: 795
  year: 2006
  end-page: 801
  article-title: Split‐face comparison of photodynamic therapy with 5‐aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage
  publication-title: Dermatol Surg
– volume: 136
  start-page: 891
  year: 1990
  end-page: 897
  article-title: Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5‐aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
  publication-title: Am J Pathol
– volume: 16
  start-page: 340
  year: 2006
  end-page: 348
  article-title: Photodynamic therapy in dermatology
  publication-title: Eur J Dermatol
– volume: 33
  start-page: 449
  year: 2007
  end-page: 454
  article-title: Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color
  publication-title: Dermatol Surg
– volume: 141
  start-page: 1247
  year: 2005
  end-page: 1252
  article-title: Topical 5‐aminolevulinic acid combined with intense pulsed light in the treatment of photoaging
  publication-title: Arch Dermatol
– volume: 136
  start-page: 891
  year: 1990
  ident: e_1_2_5_3_2
  article-title: Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5‐aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
  publication-title: Am J Pathol
– volume: 17
  start-page: 115
  year: 2007
  ident: e_1_2_5_6_2
  article-title: Photodynamic therapy in aesthetic dermatology
  publication-title: Aesthetic Dermatol
– start-page: 537
  volume-title: Cancer Medicine
  year: 2006
  ident: e_1_2_5_2_2
– ident: e_1_2_5_7_2
  doi: 10.1111/j.1524-4725.2005.31924
– ident: e_1_2_5_8_2
  doi: 10.1111/j.1524-4725.2007.33092.x
– ident: e_1_2_5_10_2
  doi: 10.1080/147641700510037725
– volume: 16
  start-page: 340
  year: 2006
  ident: e_1_2_5_4_2
  article-title: Photodynamic therapy in dermatology
  publication-title: Eur J Dermatol
– ident: e_1_2_5_11_2
  doi: 10.1001/archderm.141.10.1247
– ident: e_1_2_5_12_2
  doi: 10.1111/j.1524-4725.2006.32163.x
– ident: e_1_2_5_5_2
  doi: 10.1016/j.det.2006.09.013
– volume: 4
  start-page: 35
  year: 2005
  ident: e_1_2_5_9_2
  article-title: Photorejuvenation of facial skin with topical 20% 5‐aminolevulinic acid and intense pulsed light treatment: a split face comparison study
  publication-title: J Drugs Dermatol
SSID ssj0029510
Score 2.0186162
Snippet Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) (ALA‐PDT) using intense pulsed light (IPL) as a light source (IPL‐ALA‐PDT) has been used for...
Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) (ALA-PDT) using intense pulsed light (IPL) as a light source (IPL-ALA-PDT) has been used for...
SourceID proquest
pubmed
crossref
wiley
nii
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1005
SubjectTerms 5-aminolevulinic acid photodynamic therapy
Adult
Aminolevulinic Acid - administration & dosage
Aminolevulinic Acid - adverse effects
Asian
Asian Continental Ancestry Group
Cosmetic Techniques
Face
Female
Fluorescence
Follow-Up Studies
Humans
intense pulsed light
Middle Aged
photoaging
Photochemotherapy - adverse effects
Photochemotherapy - methods
Photosensitizing Agents - administration & dosage
Photosensitizing Agents - adverse effects
Regression Analysis
Rejuvenation
Skin Aging - drug effects
Skin Aging - ethnology
Treatment Outcome
Title Comparative split-face study of 5-aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin
URI https://api.istex.fr/ark:/67375/WNG-LG59RKC8-P/fulltext.pdf
https://cir.nii.ac.jp/crid/1573668925623547392
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1346-8138.2010.00946.x
https://www.ncbi.nlm.nih.gov/pubmed/21083701
https://www.proquest.com/docview/808460594
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0385-2407
  databaseCode: DR2
  dateStart: 20060101
  customDbUrl:
  isFulltext: true
  eissn: 1346-8138
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0029510
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgL70eAIh8Qt6zysmMfq6UPFVqhioreLDt21LBLstpNEOXED-DAb-SXMONkA4t6qBCXKHE0iTMZz3zjGY8JeckKy4xL85CZUoRZUtoQdGARRs4AeC6difxeBEfH_OA0OzxjZ0P-E66F6etDjBNuODK8vsYBrs1qc5CnGQ9FnI4ZWjLjE8STccq9d3UyVpJKEEj4gIJgGFDIN5N6Ln3QhqW6gUyHput1VV0GRjexrTdOe3fIbP1ZfU7KbNK1ZlJ8_avi4__57rvk9oBh6U4vdPfINVffJzePhij9A_J9-rukOF0Bym1_fvtR6gIusJgtbUrKoEV_qupm7j53fnEm1UVl6eK8aRt7UcO9gvZrwy4ozhXTyufaO7rowJhbOsdJBQqIuydZuo8dqG0vZvj8HVwbSlezqn5ITvd2308PwmHXh7DImOBhkchER5HNNGgTK9HFyVwuY1vEhmumHZOlywV3gG6kkzkz4EHm0rKytC62ZfqIbNVN7Z4QCg1GCFla7sAg8EiDYeISnTTprHAyIPn6D6tiKImOO3PM1R-uETBbIbMVMlt5ZqsvAYlHykVfFuQKNK-8EI0EejnDtLqcqQ_H--rtPpMnb6ZCvQvINkgZ9AiPMctTzoVMEKjiRtEyCQhdy58CZYARHl27plspEQmMc8ssII97uRxfBq491jmKA8K8dF252-rw9S6cPP1HumfkVjJmAD0nW-2yc9uA41rzwo_QX2iBOOk
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BK0EvvB8GCntA3Bz5tevdYxXahjaJUNWK3la2dy1MUjtKbEQ58QM48Bv5JcysHUNQDxXiYtkbjWOPZ2e-2ZmdIeQ1yzRLTRi7LM2FGwW5dkEHZq5nUgDPuUk924tgMuWjs-jonJ137YBwL0xbH6JfcMOZYfU1TnBckN6c5WHEXeGHfYqWjPgAAOV2xMFtQYR00teSChBK2JCCYBhSiDfTeq6804at2ka2w9DNsiiugqOb6Naap4O7ZL5-sTYrZTZo6nSQff2r5uN_evN75E4HY-leK3f3yQ1TPiC3Jl2g_iH5PvxdVZyuAOjWP7_9yJMMLrCeLa1yymAkuSjKam4-N3Z_Jk2yQtPFx6qu9GUJv2W03R52SXG5mBY23d7QRQP2XNM5ritQAN0tydJ8akBzW0nD--_h9lC6mhXlI3J2sH86HLld4wc3i5jgbhbIIPE8HSWgULRELycysfR15qc8YYlhMjex4AYAjjQyZik4kbHULM-18XUePiZbZVWap4TCQCqEzDU3YBO4l4Bt4hL9NGm0MNIh8foTq6yrio7NOebqD-8ImK2Q2QqZrSyz1ReH-D3loq0Mcg2aN1aKeoJkOcPMupipD9NDNT5k8uR4KNR7h-yCmMET4dFncci5kAFiVewVLQOH0LUAKtAHGORJSlM1KyU8gaFuGTnkSSuY_Z-Bd4-ljnyHMCte135sdfR2H06e_SPdK3J7dDoZq_G76fFzshP0CUEvyFa9bMwuwLo6fWmn6y8EkT0K
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BK1VcyhsMFPaAuDnya9e7xyppWvqIqoqK3la2d1c1CXaUxBXlxA_gwG_klzCzTgxBPVSIi2VvNI49np35Zmd2hpC3rNAsN3Hqs9wKP4ms9kEHFn5gcgDP1uSB60VwMuIH58nhBbtYtgPCvTBtfYhuwQ1nhtPXOMHNVNv1WR4n3Bdh3KVoyYT3AFBuJkwKzO8bnHW1pCKEEi6kIBiGFNL1tJ4b77RmqzaR7TB0tyrLm-DoOrp15ml4n0xWL9ZmpYx7zSLvFV__qvn4n978Adlewli628rdQ3LHVI_I1skyUP-YfO__ripO5wB0Fz-__bBZARdYz5bWljIYyT6XVT0xV43bn0mzotR0elkvan1dwW8FbbeHXVNcLqalS7c3dNqAPdd0gusKFEB3SzIznxrQ3E7S8P67uD2Uzsdl9YScD_c-9A_8ZeMHv0iY4H4RySgLAp1koFC0RC8nMakMdRHmPGOZYdKaVHADAEcambIcnMhUamatNqG28VOyUdWVeU4oDORCSKu5AZvAgwxsE5fop0mjhZEeSVefWBXLqujYnGOi_vCOgNkKma2Q2coxW33xSNhRTtvKILegeeekqCPIZmPMrEuZ-jjaV8f7TJ4d9YU69cgOiBk8ER5DlsacCxkhVsVe0TLyCF0JoAJ9gEGerDJ1M1ciEBjqlolHnrWC2f0ZePdY6ij0CHPidevHVoeDPTh58Y90b8jW6WCojt-Pjl6Se1GXD_SKbCxmjdkBVLfIX7vZ-gtX9TyO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+split-face+study+of+5-aminolevulinic+acid+photodynamic+therapy+with+intense+pulsed+light+for+photorejuvenation+of+Asian+skin&rft.jtitle=Journal+of+dermatology&rft.au=KOSAKA%2C+Sachiko&rft.au=YASUMOTO%2C+Minako&rft.au=AKILOV%2C+Oleg+E.&rft.au=HASAN%2C+Tayyaba&rft.date=2010-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0385-2407&rft.eissn=1346-8138&rft.volume=37&rft.issue=12&rft.spage=1005&rft.epage=1010&rft_id=info:doi/10.1111%2Fj.1346-8138.2010.00946.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_LG59RKC8_P
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2407&client=summon